-
Zyprexa
- Gen: Olanzapine,
- Class: Antipsychotic (Thienobenzadiazepine),
- RoA: Oral, IM,
- MOA: D2, 5HT2 antagonist,
- Indication: Schizophrenia, Bipolar
-
Lupron Depot
- Gen: Leuprolide Acetate,
- Class: Antineoplastic Agent, LHRH Agonist,
- RoA: IV, IM, ID, SC,
- MOA: Gonadotropin-releasing Hormone (GnRH), Luteinizing H-Releasing H,
- Indication: Anemia, Endometriosis, Prostate cancer
-
Prevacid
- Gen: Lansoprazole,
- Class: PPI,
- RoA: Oral,
- MOA: inhibits acid secretion by covalently binding the H/K ATPase pump,
- Indication: DU, GERD, NSAID-GU, Zollinger-Ellison syndrome
-
Zithromax
- Gen: Azithromycin,
- Class: Antibiotic (macrolide),
- RoA: Oral,
- MOA: binds 50-S ribosomal subunit (interferes with microbial protein synthesis),
- Indication: COPD, otitis media, conjunctivitis, pneumonia, gonorrhea (bacterial infections)
-
Lipitor
- Gen: Atorvastatin,
- Class: Antihyperlipidemic, HMG-CoA reductase Inhibitor,
- RoA: Oral,
- MOA: inhibits cholesterol synthesis, increases LDL receptors,
- Indication: Hypercholesterolemia, hyperglyceridemia, Familial type-3 hyperlipoproteinemia, CVD (prophylaxis), type 2 diabetes mellitus
-
Cubicin
- Gen: Daptomycin,
- Class: Antibiotic, Lipopeptide,
- RoA: IV,
- MOA: binds cell membrane depolarizing membrane potential leading to disrupt DNA, RNA and protein synthesis,
- Indication: Bacteremia, endocarditis, staph aureus
-
Suprane
- Gen: Desflurane,
- Class: Haloalkane, Anesthetic,
- RoA: Inhalation,
- MOA: increase GABA transmission, disrupts lipid matrix of neuronal membranes affecting gating of ion channels,
- Indication: General anesthesia
-
Cardene I.V.
- Gen: Nicardipine,
- Class: Anti-HT, CCBlocker,
- RoA: IV, oral,
- MOA: blocks the transmembrane influx of Ca+ affecting cardiac/SM contractility,
- Indication: HT, postoperative HT, Stable angina
-
Adenoscan
- Gen: Adenosine,
- Class: Adenosine R-agonist, Antiarrhythmic,
- RoA: IV,
- MOA: slows impulse formation SA node, and conduction of AV node (influence cellular Ca dynamics),
- Indication: Paroxysmal supraventricular tachycardia
-
Synagis
- Gen: Palivizumab,
- Class: Immunological Agent, (Mab) RSV-I,
- RoA: IM,
- MOA: exhibits neutralizing and fusion-inhibitory activity,
- Indication: Respiratory syncytial virus infection (RSV)
|
|
